Long COVID was a term initially coined by patients in 2020 at a time where the medical and research world was distracted with the purpose of creating an effective COVID-19 vaccine. Now over 4 years on we're learned a lot about this complex illness but there's still several uncertainties in the medical world, general population and life insurance/disability context.
Join us as we endeavour to make some sense of the uncertainties by tapping into the minds of our diverse panel of experts.
Zhan Wang, Co-founder of Azuria Partners and Chair of Actuaries Institute Long Covid Working Group
Dr Tope Ogundare MBBS BMedSc, Lead Medical Officer (Technical) TAL
Libuska Prochazka, Rehabilitation Consultant/Shared Value Manager, AIA
This is an online event.
1 point(s) – Business, Technical and Specialist